Summary
PsychoGenics Inc (PsychoGenics) is an preclinical contract research organization that offers contract research, standard and customized preclinical services and drug discovery services. The organization offers various behavioral tests to drug candidates in the areas of pain and inflammation, psychiatric and neurodegenerative disorders, and spinal cord and traumatic brain injury. Its phenocube is used to identify compounds with potential to treat cognitive impairment. PsychoGenics offers behavioral testing, electrophysiology, microdialysis, and other services. The organization caters to biotechnology, pharmaceutical, and other sectors. PsychoGenics is headquartered in Tarrytown, New York, the US.
PsychoGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 10
PGI Drug Discovery And Roche Expand Drug Discovery Agreement 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis' ESP Technology For Drug Discovery 13
PsychoGenics Enters Into Joint Venture Agreement With KineMed 14
Licensing Agreements 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 16
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 17
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 18
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 19
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 20
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 21
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 22
PsychoGenics Inc - Key Competitors 23
PsychoGenics Inc - Key Employees 24
PsychoGenics Inc - Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Other Significant Developments 26
Jan 19, 2016: PsychoGenics Expands its Drug Discovery Service Capabilities 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
PsychoGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 10
PGI Drug Discovery And Roche Expand Drug Discovery Agreement 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis' ESP Technology For Drug Discovery 13
PsychoGenics Enters Into Joint Venture Agreement With KineMed 14
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 16
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 17
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 18
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 19
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 20
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 21
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 22
PsychoGenics Inc, Key Competitors 23
PsychoGenics Inc, Key Employees 24
List of Figures
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
